The future of stenting

R. S. Schwartz, David Holmes

Research output: Contribution to journalArticle

Abstract

The era of intracoronary stenting has arrived, with two proven clinical applications: as bail-out for failed angioplasty, and for long-term effects on decreasing restenosis. Stent restenosis occurs because of neointimal hyperplasia, since the stent effectively deals with remodelling. Stents of the current generation exhibit only mechanical effects, and lack biologic activity to inhibit neointimal thickness. The future of stenting centres on improved mechanical and delivery features, as well as developing biological activity. In the future the stent will come to fully realize its full potential, with potent mechanical and biological properties.

Original languageEnglish (US)
Pages (from-to)221-223
Number of pages3
JournalMinimally Invasive Therapy and Allied Technologies
Volume6
Issue number3
DOIs
StatePublished - Jan 1 1997

Fingerprint

Stents
Angioplasty
Hyperplasia

Keywords

  • Heparin
  • Neointimal hyperplasia
  • Restenosis
  • Stent

ASJC Scopus subject areas

  • Surgery

Cite this

The future of stenting. / Schwartz, R. S.; Holmes, David.

In: Minimally Invasive Therapy and Allied Technologies, Vol. 6, No. 3, 01.01.1997, p. 221-223.

Research output: Contribution to journalArticle

Schwartz, R. S. ; Holmes, David. / The future of stenting. In: Minimally Invasive Therapy and Allied Technologies. 1997 ; Vol. 6, No. 3. pp. 221-223.
@article{d1acc724657c45399cbbe8b167baa03c,
title = "The future of stenting",
abstract = "The era of intracoronary stenting has arrived, with two proven clinical applications: as bail-out for failed angioplasty, and for long-term effects on decreasing restenosis. Stent restenosis occurs because of neointimal hyperplasia, since the stent effectively deals with remodelling. Stents of the current generation exhibit only mechanical effects, and lack biologic activity to inhibit neointimal thickness. The future of stenting centres on improved mechanical and delivery features, as well as developing biological activity. In the future the stent will come to fully realize its full potential, with potent mechanical and biological properties.",
keywords = "Heparin, Neointimal hyperplasia, Restenosis, Stent",
author = "Schwartz, {R. S.} and David Holmes",
year = "1997",
month = "1",
day = "1",
doi = "10.3109/13645709709153324",
language = "English (US)",
volume = "6",
pages = "221--223",
journal = "Minimally Invasive Therapy and Allied Technologies",
issn = "1364-5706",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - The future of stenting

AU - Schwartz, R. S.

AU - Holmes, David

PY - 1997/1/1

Y1 - 1997/1/1

N2 - The era of intracoronary stenting has arrived, with two proven clinical applications: as bail-out for failed angioplasty, and for long-term effects on decreasing restenosis. Stent restenosis occurs because of neointimal hyperplasia, since the stent effectively deals with remodelling. Stents of the current generation exhibit only mechanical effects, and lack biologic activity to inhibit neointimal thickness. The future of stenting centres on improved mechanical and delivery features, as well as developing biological activity. In the future the stent will come to fully realize its full potential, with potent mechanical and biological properties.

AB - The era of intracoronary stenting has arrived, with two proven clinical applications: as bail-out for failed angioplasty, and for long-term effects on decreasing restenosis. Stent restenosis occurs because of neointimal hyperplasia, since the stent effectively deals with remodelling. Stents of the current generation exhibit only mechanical effects, and lack biologic activity to inhibit neointimal thickness. The future of stenting centres on improved mechanical and delivery features, as well as developing biological activity. In the future the stent will come to fully realize its full potential, with potent mechanical and biological properties.

KW - Heparin

KW - Neointimal hyperplasia

KW - Restenosis

KW - Stent

UR - http://www.scopus.com/inward/record.url?scp=0030743665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030743665&partnerID=8YFLogxK

U2 - 10.3109/13645709709153324

DO - 10.3109/13645709709153324

M3 - Article

AN - SCOPUS:0030743665

VL - 6

SP - 221

EP - 223

JO - Minimally Invasive Therapy and Allied Technologies

JF - Minimally Invasive Therapy and Allied Technologies

SN - 1364-5706

IS - 3

ER -